Bastien Gerby

1.1k total citations
18 papers, 530 citations indexed

About

Bastien Gerby is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Hematology. According to data from OpenAlex, Bastien Gerby has authored 18 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 10 papers in Oncology and 8 papers in Hematology. Recurrent topics in Bastien Gerby's work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (6 papers) and CAR-T cell therapy research (6 papers). Bastien Gerby is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (6 papers) and CAR-T cell therapy research (6 papers). Bastien Gerby collaborates with scholars based in France, Canada and United States. Bastien Gerby's co-authors include André Baruchel, Paola Ballerini, Françoise Pflumio, Jean Soulier, Emmanuelle Clappier, Florence Armstrong, Paul‐Henri Roméo, Luis M. Hernández, Marc Delord and François Sigaux and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Bastien Gerby

18 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bastien Gerby France 9 231 220 211 142 112 18 530
Barbara Szymanska Australia 6 306 1.3× 155 0.7× 125 0.6× 140 1.0× 75 0.7× 7 499
W-D Ludwig Germany 13 397 1.7× 213 1.0× 278 1.3× 190 1.3× 148 1.3× 13 756
Victoria Grandage United Kingdom 9 492 2.1× 264 1.2× 472 2.2× 177 1.2× 92 0.8× 16 926
Denise Niewerth Netherlands 12 530 2.3× 80 0.4× 322 1.5× 240 1.7× 59 0.5× 20 697
Júlia Starková Czechia 16 293 1.3× 234 1.1× 204 1.0× 54 0.4× 40 0.4× 44 548
N. Roubi France 6 558 2.4× 83 0.4× 377 1.8× 232 1.6× 108 1.0× 8 809
Terry J. Gaymes United Kingdom 13 585 2.5× 80 0.4× 280 1.3× 265 1.9× 80 0.7× 24 800
Heather Bendall United States 8 244 1.1× 66 0.3× 126 0.6× 170 1.2× 182 1.6× 14 628
Marjolein A. van der Pol Netherlands 8 169 0.7× 41 0.2× 231 1.1× 170 1.2× 82 0.7× 10 450
René Marke Netherlands 4 271 1.2× 95 0.4× 289 1.4× 94 0.7× 83 0.7× 8 481

Countries citing papers authored by Bastien Gerby

Since Specialization
Citations

This map shows the geographic impact of Bastien Gerby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bastien Gerby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bastien Gerby more than expected).

Fields of papers citing papers by Bastien Gerby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bastien Gerby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bastien Gerby. The network helps show where Bastien Gerby may publish in the future.

Co-authorship network of co-authors of Bastien Gerby

This figure shows the co-authorship network connecting the top 25 collaborators of Bastien Gerby. A scholar is included among the top collaborators of Bastien Gerby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bastien Gerby. Bastien Gerby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Largeaud, Laëtitia, Naïs Prade, Christine Didier, et al.. (2025). GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome. Blood Cancer Journal. 15(1). 7–7. 2 indexed citations
2.
Largeaud, Laëtitia, Naïs Prade, Isabelle Luquet, et al.. (2023). Stem cell–like reprogramming is required for leukemia-initiating activity in B-ALL. The Journal of Experimental Medicine. 221(1). 2 indexed citations
3.
Veiga, Diogo F. T., Mathieu Tremblay, Bastien Gerby, et al.. (2022). Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology. 13. 867443–867443. 3 indexed citations
4.
Gerby, Bastien, et al.. (2021). Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells. Cancers. 13(21). 5511–5511. 5 indexed citations
5.
Péron, Sophie, Nelly Rouquié, Naïs Prade, et al.. (2018). PAX5AandPAX5Bisoforms are both efficient to drive B cell differentiation. Oncotarget. 9(67). 32841–32854. 4 indexed citations
6.
Pasquet, Marlène, Nelly Rouquié, Naïs Prade, et al.. (2018). PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice. Proceedings of the National Academy of Sciences. 115(41). 10357–10362. 18 indexed citations
7.
Gerby, Bastien, Cédric S. Tremblay, Mathieu Tremblay, et al.. (2014). SCL, LMO1 and Notch1 Reprogram Thymocytes into Self-Renewing Cells. PLoS Genetics. 10(12). e1004768–e1004768. 51 indexed citations
8.
Gerby, Bastien, et al.. (2014). NUP98-PHF23 and NUP98-HOXD13 oncogenes confer aberrant self-renewal potential to thymocyte progenitors. Experimental Hematology. 42(8). S62–S62. 1 indexed citations
9.
Gerby, Bastien. (2014). SCL, LMO1 and NOTCH1 reprogram thymocytes into self-renewing cells. Experimental Hematology. 42(8). S35–S35. 5 indexed citations
10.
Lacombe, Julie, Gorazd Krosl, Mathieu Tremblay, et al.. (2013). Genetic interaction between Kit and Scl. Blood. 122(7). 1150–1161. 19 indexed citations
11.
Gerby, Bastien & Trang Hoang. (2013). Modelling acute leukemias in mice: clonal evolution and the emergence of leukemic stem cells. BMC Proceedings. 7(S2). K1–K1. 1 indexed citations
12.
Gerby, Bastien, Emmanuelle Clappier, Florence Armstrong, et al.. (2011). Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations. Leukemia. 25(8). 1249–1258. 50 indexed citations
13.
Clappier, Emmanuelle, Bastien Gerby, François Sigaux, et al.. (2011). Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. The Journal of Experimental Medicine. 208(4). 653–661. 138 indexed citations
14.
Kusy, Sophie, Bastien Gerby, Nicolas Goardon, et al.. (2010). NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia. The Journal of Experimental Medicine. 207(10). 2141–2156. 50 indexed citations
15.
Gerby, Bastien, José Olivares, Jean Boutonnât, et al.. (2010). Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistance.. PubMed. 30(7). 2553–9. 2 indexed citations
16.
Armstrong, Florence, Philippe Brunet de la Grange, Bastien Gerby, et al.. (2008). NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity. Blood. 113(8). 1730–1740. 116 indexed citations
17.
Gerby, Bastien, Ahcène Boumendjel, Madeleine Blanc, et al.. (2006). 2-Arylidenedihydroindole-3-ones: Design, synthesis, and biological activity on bladder carcinoma cell lines. Bioorganic & Medicinal Chemistry Letters. 17(1). 208–213. 25 indexed citations
18.
Boumendjel, Ahcène, E. Nicolle, Bastien Gerby, et al.. (2005). Piperazinobenzopyranones and Phenalkylaminobenzopyranones:  Potent Inhibitors of Breast Cancer Resistance Protein (ABCG2). Journal of Medicinal Chemistry. 48(23). 7275–7281. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Szymanska Breakdown of academic impact, for papers by W-D Ludwig Breakdown of academic impact, for papers by Victoria Grandage Breakdown of academic impact, for papers by Denise Niewerth Breakdown of academic impact, for papers by Júlia Starková Breakdown of academic impact, for papers by N. Roubi Breakdown of academic impact, for papers by Terry J. Gaymes Breakdown of academic impact, for papers by Heather Bendall Breakdown of academic impact, for papers by Marjolein A. van der Pol Breakdown of academic impact, for papers by René Marke
Rankless by CCL
2026